The antibody contract manufacturing market is projected to reach USD 17 billion by 2030 With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone For additional details, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html